Advertisement

Document › Details
AB Science S.A.. (2/28/22). "Press Release: Financing of 8.5 Million Dollars through the Issuance of Convertible Bonds with Attached Warrants (with a Conversion Price of EUR 14.0) [Not for US, CA, AU or JP]". Paris.
![]() |
Organisation | AB Science S.A. (NYSE Euronext - FR0010557264 - AB) |
Group | AB Science (Group) | |
![]() |
Product | masitinib |
Product 2 | investment banking | |
Original document
accessed by [iito] on 2022-02-28
Record changed: 2022-03-03 |
Advertisement
![Picture [iito] No Tracking 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-tracking.jpg)
More documents for AB Science (Group)
- [1] AB Science S.A.. (5/12/17). "Press Release: AB Science Announces that ANSM Requested the Temporary Suspension of Clinical Studies Conducted in France Following Deviations from Good Clinical Practice (GCP) Standards". Paris....
- [2] AB Science S.A.. (3/31/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris....
- [3] AB Science S.A.. (3/27/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris....
- [4] AB Science S.A.. (9/29/16). "Press Release: Filing of Masitinib in the Treatment of Amyotrophic Lateral Sclerosis (ALS) to the European Medicines Agency (EMA)". Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top